ScripAfter the year’s slow start, venture capital fundraising by drug developers has gotten a big boost in recent months, especially in May when two companies raised more than $700m between them – $300m fo
ScripIt appears that the biopharmaceutical industry is on its way to not only beat but completely demolish prior venture capital fundraising records, based on totals for the first half of 2020 reported in